Effects of hammerhad ribozyme targeting connective tissue growth factor on collagen Ⅰ synthesis and cell cycle progression of human hepatic stellate cells

Xiao-yan QI,Run-ping GAO,Rui-juan ZHANG,Guo-feng LI,Yong-guang YANG
DOI: https://doi.org/10.13481/j.1671-587x.2009.01.022
2009-01-01
Abstract:Objective: To study the inhibitory effect of hammerhead ribozyme targeting connective tissue growth factor (CTGF) on collagen I synthesis and cell cycle progression of human hepatic stellate cell line (LX-2) cells. Methods: Hammerhead ribozyme cDNA targeting CTGF rnRNA plus two self-cleaving sequences were inserted into pTriEx2 vector to construct a recombinant vector pTriCTGF-Rz. LX-2 cells were transfected with either pTriEx2 or pTriCTGF-Rz and further stimulated with or without TGF-1. There were five groups in the experiment: control group, pTriEx2 group, pTriCTGF-Rz group, pTriEx2 plus TGF-β1 group, and pTrCTGF-Rz plus TGF-β1 group. Semi-quantitative RT-PCR was used to detect the levels of CTGF mRNA and collagen I mRNA. ELISA and flow cytometry were used to detect the levels of collagen I secretion and cell cycle. Results: Transfection of pTriCTGF-Rz into LX-2 cells reduced the CTGF mRNA and collagen I mRNA levels as well as collagen I protein level compared with pTriEx2 group (P < 0.05). TGF- 1-induced CTGF mRNA and collagen I mRNA transcription were decreased in LX-2 cells transfected with pTriCTGF-Rz compared with control groups (P<0.05). Furthermore, in the LX-2 cells transfected with pTriCTGF-Rz, the proportion of cells at G0-G1 phase increased (P<0.05) and that of cells at S phase decreased (P < 0.01) compared with control group. Conclusion: The hammerhead ribozyme targeting CTGF has inhibitory effects on human hepatic stellate cell-mediated fibrosis and it may become another candidate for gene therapy in the future.
What problem does this paper attempt to address?